Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morag J Young

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Expert Opinion on Therapeutic Targets|January 18, 2013
Targeting the mineralocorticoid receptor in cardiovascular diseaseMorag J Young
Current Opinion in Nephrology and Hypertension|February 16, 2008
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammationMorag J Young
Current Opinion in Pharmacology|November 18, 2020
Corticosteroids and circadian rhythms in the cardiovascular systemMonica Kanki, Morag J Young
Journal of Molecular and Cellular Cardiology|January 16, 2026
The mineralocorticoid receptor: a new chapter for therapeutic regulation of diabetic cardiomyopathyMonica Kanki, Morag J Young
Current Opinion in Pharmacology|March 4, 2016
Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differencesJun Yang, Morag J Young
Journal of Molecular Endocrinology|July 21, 2009
The mineralocorticoid receptor and its coregulatorsJun Yang, Morag J Young
Journal of Hypertension|August 13, 2002
Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular systemMorag J Young, John W Funder
Molecular and Cellular Endocrinology|September 21, 2011
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosisMorag J Young, Amanda J Rickard
Expert Opinion on Therapeutic Targets|February 14, 2008
6th International Symposium on Aldosterone and ENaC: from gene to disease. 3-7 October 2007, Zermatt, SwitzerlandPeter J Fuller, Morag J Young
Endocrinology|November 6, 2012
Corticosteroids, heart failure, and hypertension: a role for immune cells?Jimmy Z Shen, Morag J Young
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Expert Opinion on Therapeutic Targets|January 18, 2013
Targeting the mineralocorticoid receptor in cardiovascular diseaseMorag J Young
Current Opinion in Nephrology and Hypertension|February 16, 2008
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammationMorag J Young
Current Opinion in Pharmacology|November 18, 2020
Corticosteroids and circadian rhythms in the cardiovascular systemMonica Kanki, Morag J Young
Journal of Molecular and Cellular Cardiology|January 16, 2026
The mineralocorticoid receptor: a new chapter for therapeutic regulation of diabetic cardiomyopathyMonica Kanki, Morag J Young
Current Opinion in Pharmacology|March 4, 2016
Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differencesJun Yang, Morag J Young
Journal of Molecular Endocrinology|July 21, 2009
The mineralocorticoid receptor and its coregulatorsJun Yang, Morag J Young
Journal of Hypertension|August 13, 2002
Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular systemMorag J Young, John W Funder
Molecular and Cellular Endocrinology|September 21, 2011
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosisMorag J Young, Amanda J Rickard
Expert Opinion on Therapeutic Targets|February 14, 2008
6th International Symposium on Aldosterone and ENaC: from gene to disease. 3-7 October 2007, Zermatt, SwitzerlandPeter J Fuller, Morag J Young
Endocrinology|November 6, 2012
Corticosteroids, heart failure, and hypertension: a role for immune cells?Jimmy Z Shen, Morag J Young
Pageof 12